Assessing Phreesia: Insights From 7 Financial Analysts
Portfolio Pulse from Benzinga Insights
Phreesia (NYSE:PHR) has received mixed reviews from 7 financial analysts over the past quarter, with recent ratings ranging from bullish to bearish. The average 12-month price target for PHR has been adjusted to $29.29, down from $37.25, indicating a 21.37% decrease. Analysts have adjusted their ratings and price targets in response to market dynamics and Phreesia's performance, with some maintaining their positive outlook while others have lowered their expectations. Phreesia's financials show a positive revenue trend with a 25.33% growth rate as of October 31, 2023, but its net margin and ROA lag behind industry averages, despite a strong ROE and prudent debt management.
February 26, 2024 | 6:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Phreesia has seen a diverse range of analyst ratings, with a notable decrease in the average price target to $29.29, indicating potential short-term pressure on the stock. Despite this, the company's strong revenue growth and prudent debt management may offer some support.
The decrease in the average price target suggests analysts are adjusting their expectations due to market dynamics and Phreesia's performance. While the positive revenue trend and low debt-to-equity ratio are encouraging, the lowered price targets and mixed ratings indicate potential short-term downside risk for PHR's stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100